NOI Sole Source - Siemens Healthcare SL PR 12480015.pdf

NOTICE OF INTENT FOR SOLE SOURCE ACQUISITION:

This notice is being published in accordance with Revolutionary FAR Overhaul (RFO)

Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a Notice of Intent (NOI) to award a sole source contract and is not a request for competitive quotes/proposals. The Defense Health Agency Healthcare

Contracting Division Southeast (DHACA-HCD-SE) is issuing this NOI to inform industry contractors of the Government’s intent to execute a sole source contract under RFO FAR

13.5, Simplified Procedures for Certain Commercial Products and Commercial Services.

This notice satisfies posting requirements at FAR Part 5.101. The intended source is Siemens

Healthcare SL. Place of Performance is Naval Hospital Rota Spain. Requirement is for a five

(5)-year service contract (base plus four (4) options) for HEMATOLOGY, COAGULATION, ANALYZER, LABORATORY ECN 093733 MODEL CA-620 and

HEMATOLOGY, COAGULATION, ANALYZER, LABORATORY, ECN 093734

MODEL CA-620. This contract will require an all-inclusive hematology Analyzer Reagent

Delivery and Maintenance program. The vendor shall provide continuous, uninterrupted delivery of all necessary reagents, calibrators, quality controls, and consumable supplies required to operate contractor-placed hematology analyzers. The North American Industry

Classification System (NAICS) for this requirement is 621999.

This Notice of Intent is neither a formal solicitation, nor a request for competitive proposals.

No solicitation document is available, and telephone requests will not be honored. No award will be made based on unsolicited quotations or offers received in response to this notice.

Any response to this notice must show clear, compelling, and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. All inquiries and concerns must be addressed in writing via email to Kimberly Bunn at

Kimberly.p.Bunn.civ@health.mil and Melissa Peregrino at melissa.peregrino-white.civ@health.mil with the following information referenced in the subject line, Hematology, Coagulation Analyzers - Naval Hospital Rota Spain. All interested parties who are responsible, certified, and capable may identify their interest and may submit a capabilities statement.

Capability statements shall not exceed five (5) (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by closing of this notification of this synopsis will be considered by the government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response.

The burden of proof is on the respondent with the submittal of their Capability Statement and addressing the entire need as outlined in the Performance Work Statement. A determination by the government not to compete based on responses to this notice is solely within the discretion of the government.

Kimberly.p.Bunn.civ@health.mil mailto:melissa.peregrino-white.civ@health.mil mailto:melissa.peregrino-white.civ@health.mil

Capability statements shall be submitted by email only as a Microsoft Word or Adobe PDF attachment to the Contract Specialist Kimberly Bunn at Kimberly.p.Bunn.civ@health.mil and Contracting Officer, Melissa Peregrino, melissa.peregrino-white.civ@health.mil no later than 12:00 pm Eastern Standard Time (EST) 8 September 2026 to the above listed contact.

The interested parties bear full responsibility to ensure complete transmission and timely receipt.

Prepared and Approved by:

Kimberly Bunn

Contract Specialist

Melissa Peregrino

Contracting Officer mailto:Kimberly.p.Bunn.civ@health.mil mailto:melissa.peregrino-white.civ@health.mil